Pharmicell Co

Pharmicell Co EBIT Margin

The EBIT Margin (Operating Margin) of Pharmicell Co (005690.KS) as of Nov 5, 2026 is 30.08 %. In the previous year, EBIT Margin (Operating Margin) was 7.18 % — a change of 318.93% (higher).

EBIT Margin

30.08 %

YoY

318.93%

Last updated:

EBIT Margin (Operating Margin) of Pharmicell Co is 2025 30.08 % . EBIT Margin (Operating Margin) of Pharmicell Co was 2024 7.18 % . It decreases by 318.93% higher compared to the previous year.

For Pharmicell Co, the operating (EBIT) margin of 30.1% is up versus 21.1% a few years ago.

The Pharmicell Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
0.92 KRW
Jan 1, 2019
6.05 KRW
Jan 1, 2020
19.16 KRW
Jan 1, 2021
21.11 KRW
Jan 1, 2022
14.74 KRW
Jan 1, 2023
2.30 KRW
Jan 1, 2024
7.18 KRW
Jan 1, 2025
30.08 KRW
The Pharmicell Co EBIT Margin history
YEAREBIT MarginYoY
30.08 %+318.93%
7.18 %+211.46%
2.30 %-84.37%
14.74 %-30.15%
21.11 %+10.16%
19.16 %+216.96%
6.05 %+558.74%
0.92 %-105.19%
-17.70 %+164.07%
-6.70 %-69.50%
-21.97 %-47.39%
-41.77 %+17,677.96%
-0.23 %-81.68%
-1.28 %-14.26%
-1.50 %+3.03%
-1.45 %+319.56%
-0.35 %-13.73%
-0.40 %+138.26%
-0.17 %+18.79%
-0.14 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pharmicell Co Stock analysis

What does Pharmicell Co do? Pharmicell Co., Ltd. develops stem cell-based pharmaceuticals and technologies, focusing on stem cell therapeutic drugs and stem cell-based cosmetics. The company provides stem cell storage services and supplies mesenchymal stem cells (MSCs) for research purposes. It also operates a fashion business under the brand names Religion and Day, offering women’s and men’s apparel. The company merged with its wholly owned subsidiary on March 31, 2013, which was primarily engaged in medicine manufacturing and sales. Pharmicell generates revenue through its biopharmaceutical division, selling stem cell therapeutic drugs and cosmetics, as well as stem cell storage services and MSCs for research. The fashion business contributes through the sale of apparel under the Religion and Day brands. The primary buyers for pharmaceutical products include healthcare providers and research institutions, while the fashion segment targets consumers purchasing women’s and men’s clothing. The company’s segments are biopharmaceuticals, stem cell services, and fashion apparel. The biopharmaceutical business develops and manufactures stem cell-based drugs and cosmetics, with MSCs used in research areas. The fashion segment operates under the brand names Religion and Day, providing women’s and men’s apparel. The company’s revenue streams are derived from the sale of therapeutic drugs, cosmetics, stem cell storage, MSCs for research, and apparel sales. The merged subsidiary’s medicine manufacturing and sales activity complements the core biopharmaceutical operations. Pharmicell Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmicell Co stock

EBIT Margin (Operating Margin) of Pharmicell Co is 30.08 % in 2025.

EBIT Margin (Operating Margin) of Pharmicell Co changed from 7.18 % to 30.08 %, representing a 318.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Pharmicell Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Pharmicell Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Pharmicell Co

All Key Metrics — Pharmicell Co